Literature DB >> 9867746

Prevalence of elevated serum transferrin saturation in adults in the United States.

A C Looker1, C L Johnson.   

Abstract

BACKGROUND: A population-based hemochromatosis screening program that uses serum transferrin saturation has been proposed, but few data exist on the number of U.S. adults that such a program would identify for further testing.
OBJECTIVE: To determine the prevalence of an initially elevated serum transferrin saturation and the prevalence of concurrently elevated serum transferrin saturation and serum ferritin levels in the adult population of the United States.
DESIGN: Nationally representative cross-sectional survey of the noninstitutionalized U.S. civilian population. PARTICIPANTS: 15 839 men and nonpregnant women 20 years of age and older who were examined in the third National Health and Nutrition Examination Survey (1988-1994). MEASUREMENTS: Single measurements of serum transferrin saturations and serum ferritin levels. Cut-off values used to define elevated serum transferrin saturation ranged from greater than 45% to greater than 62%.
RESULTS: The prevalence of initially elevated serum transferrin saturation ranged from 1% to 6%. Approximately 11% to 22% of those with elevated serum transferrin saturation had concurrently elevated serum ferritin levels. The prevalence of elevated serum transferrin saturation was lower in women than in men when the same cut-off value was used to define elevated serum transferrin saturation. The prevalence of elevated serum transferrin saturation in non-Hispanic black persons and Mexican-Americans was similar to or slightly less than that in non-Hispanic white persons. The prevalence of elevated serum transferrin saturation in persons 20 to 49 years of age was as high as or higher than that in older adults.
CONCLUSIONS: A hemochromatosis screening program that uses a cut-off value of greater than 60% to define elevated serum transferrin saturation would identify an estimated 1.4 to 2.5 million U.S. adults for further testing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867746     DOI: 10.7326/0003-4819-129-11_part_2-199812011-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

1.  Elevated serum transferrin saturation and mortality.

Authors:  Arch G Mainous; James M Gill; Peter J Carek
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

2.  Targeted screening for genetic haemochromatosis: a combined phenotype/genotype approach.

Authors:  M Bhavnani; D Lloyd; J Marples; K Pendry; M Worwood
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

3.  Transferrin saturation, dietary iron intake, and risk of cancer.

Authors:  Arch G Mainous; James M Gill; Charles J Everett
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

4.  The mortality risk of elevated serum transferrin saturation and consumption of dietary iron.

Authors:  Arch G Mainous; Brian Wells; Peter J Carek; James M Gill; Mark E Geesey
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

5.  Transferrin saturation and hospital length of stay and mortality in Medicare beneficiaries.

Authors:  Arch G Mainous; Vanessa A Diaz; Michele E Knoll; Mary M Hulihan; Althea M Grant; Robert U Wright
Journal:  J Am Geriatr Soc       Date:  2012-12-03       Impact factor: 5.562

6.  Iron mobilization during lactation reduces oxygen stores in a diving mammal.

Authors:  Michelle R Shero; Amy L Kirkham; Daniel P Costa; Jennifer M Burns
Journal:  Nat Commun       Date:  2022-08-02       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.